Brief: Sab Biotherapeutics Announces First Publication Of Promising Nonclinical Data For Therapy Against Pneumonic Plague
12/05/2023 13:42
May 12 (Reuters) - SAB Biotherapeutics Inc SABS.O :
* SAB BIOTHERAPEUTICS ANNOUNCES FIRST PUBLICATION OF
PROMISING
NONCLINICAL DATA FOR SAB-183 AGAINST PNEUMONIC PLAGUE IN THE
JOURNAL ANTIBODIES
Source text for Eikon: ID:nGNXbpSl
Further company coverage: SABS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SAB Biotherapeutics
See all newsSAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
SAB Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies